| Literature DB >> 33216198 |
Ewa Robak1, Dorota Jesionek-Kupnicka2, Tadeusz Robak3,4.
Abstract
Skin lesions have been reported in about 10-12% of hairy cell leukemia (HCL) patients. Most are etiologically related to autoimmune or infectious processes, although secondary cutaneous neoplasms and drug-induced lesions are also reported. However, leukemia cutis with the direct infiltration of the skin by leukemic cells is extremely rare in HCL patients. This paper reviews the epidemiology, pathogenesis, clinical symptoms, diagnosis, and approach to treating skin lesions in HCL. A literature review of the MEDLINE database for articles in English concerning hairy cell leukemia, skin lesions, leukemia cutis, adverse events, infectious, cutaneous, drug reactions, neutrophilic dermatoses, secondary neoplasms, and vasculitis was conducted via PubMed. Publications from January 1980 to September 2020 were scrutinized. Additional relevant publications were obtained by reviewing the references from the chosen articles.Entities:
Keywords: Adverse drug reactions; Cladribine; Cutaneous; Hairy cell leukemia; Infectious; Interferon; Leukemia cutis; Melanoma; Neutrophilic dermatoses; Secondary cancer; Skin; Skin neoplasms; Vasculitis; Vemurafenib
Mesh:
Year: 2020 PMID: 33216198 DOI: 10.1007/s00277-020-04349-z
Source DB: PubMed Journal: Ann Hematol ISSN: 0939-5555 Impact factor: 3.673